These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 33059546

  • 1. P-Tau as prognostic marker in long term follow up for patients with shunted iNPH.
    Migliorati K, Panciani PP, Pertichetti M, Borroni B, Archetti S, Rozzini L, Padovani A, Terzi L, Bruscella S, Fontanella MM.
    Neurol Res; 2021 Jan; 43(1):78-85. PubMed ID: 33059546
    [Abstract] [Full Text] [Related]

  • 2. The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.
    Craven CL, Baudracco I, Zetterberg H, Lunn MPT, Chapman MD, Lakdawala N, Watkins LD, Toma AK.
    Acta Neurochir (Wien); 2017 Dec; 159(12):2293-2300. PubMed ID: 28889317
    [Abstract] [Full Text] [Related]

  • 3. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H, Tesseur I, Pemberton D, Van Der Ark P, Timmers M, Slemmon R, Janssens L, Streffer J, Van Nueten L, Bottelbergs A, Rauramaa T, Koivisto AM, Herukka SK, Korhonen VE, Junkkari A, Hiltunen M, Engelborghs S, Blennow K, Zetterberg H, Kolb HC, Leinonen V.
    J Alzheimers Dis; 2021 Dec; 80(4):1629-1642. PubMed ID: 33720890
    [Abstract] [Full Text] [Related]

  • 4. Cerebrospinal fluid and venous biomarkers of shunt-responsive idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis.
    Thavarajasingam SG, El-Khatib M, Vemulapalli KV, Iradukunda HAS, Laleye J, Russo S, Eichhorn C, Eide PK.
    Acta Neurochir (Wien); 2022 Jul; 164(7):1719-1746. PubMed ID: 35230552
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
    Kang K, Ko PW, Jin M, Suk K, Lee HW.
    J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
    [Abstract] [Full Text] [Related]

  • 7. Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus.
    Nakajima M, Miyajima M, Ogino I, Akiba C, Sugano H, Hara T, Fusegi K, Karagiozov K, Arai H.
    J Neurol Sci; 2015 Oct 15; 357(1-2):88-95. PubMed ID: 26169158
    [Abstract] [Full Text] [Related]

  • 8. Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
    Yang F, Yang L, Fang X, Deng Y, Mao R, Yan A, Wei W.
    J Alzheimers Dis; 2023 Oct 15; 93(4):1341-1354. PubMed ID: 37182875
    [Abstract] [Full Text] [Related]

  • 9. Neuronal pentraxin 2 correlates with neurodegeneration but not cognition in idiopathic normal pressure hydrocephalus (iNPH).
    Patel M, Zhang Y, Xiao MF, Worley P, Moghekar A.
    Neurol Neurochir Pol; 2024 Oct 15; 58(1):47-53. PubMed ID: 38393959
    [Abstract] [Full Text] [Related]

  • 10. Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus.
    Nakajima M, Miyajima M, Ogino I, Akiba C, Kawamura K, Kamohara C, Fusegi K, Harada Y, Hara T, Sugano H, Tange Y, Karagiozov K, Kasuga K, Ikeuchi T, Tokuda T, Arai H.
    J Alzheimers Dis; 2018 Oct 15; 66(1):319-331. PubMed ID: 30248058
    [Abstract] [Full Text] [Related]

  • 11. Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
    Jingami N, Uemura K, Asada-Utsugi M, Kuzuya A, Yamada S, Ishikawa M, Kawahara T, Iwasaki T, Atsuchi M, Takahashi R, Kinoshita A.
    J Alzheimers Dis; 2019 Oct 15; 72(1):271-277. PubMed ID: 31561378
    [Abstract] [Full Text] [Related]

  • 12. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus.
    Kazui H, Kanemoto H, Yoshiyama K, Kishima H, Suzuki Y, Sato S, Suehiro T, Azuma S, Yoshimine T, Tanaka T.
    J Neurol Sci; 2016 Oct 15; 369():236-241. PubMed ID: 27653897
    [Abstract] [Full Text] [Related]

  • 13. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
    Jingami N, Asada-Utsugi M, Uemura K, Noto R, Takahashi M, Ozaki A, Kihara T, Kageyama T, Takahashi R, Shimohama S, Kinoshita A.
    J Alzheimers Dis; 2015 Oct 15; 45(1):109-15. PubMed ID: 25428256
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cerebral blood flow and Alzheimer's disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus.
    Azuma S, Kazui H, Kanemoto H, Suzuki Y, Sato S, Suehiro T, Matsumoto T, Yoshiyama K, Kishima H, Shimosegawa E, Tanaka T, Ikeda M.
    Psychogeriatrics; 2019 Nov 15; 19(6):527-538. PubMed ID: 30916850
    [Abstract] [Full Text] [Related]

  • 16. In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome.
    Giannini G, Baiardi S, Dellavalle S, Zenesini C, Cevoli S, Danner N, Jyrkkänen HK, Rossi M, Polischi B, Quadalti C, Stefanini C, Cortelli P, Milletti D, Herukka SK, Palandri G, Leinonen V, Parchi P.
    Fluids Barriers CNS; 2022 Sep 07; 19(1):71. PubMed ID: 36071460
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of amyloid PET scan in normal pressure hydrocephalus.
    Jang H, Park SB, Kim Y, Kim KW, Lee JI, Kim ST, Lee KH, Kang ES, Choe YS, Seo SW, Kim HJ, Kim YJ, Yoon CW, Na DL.
    J Neurol; 2018 Jan 07; 265(1):63-73. PubMed ID: 29128930
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
    Manniche C, Hejl AM, Hasselbalch SG, Simonsen AH.
    J Alzheimers Dis; 2019 Jan 07; 68(1):267-279. PubMed ID: 30741681
    [Abstract] [Full Text] [Related]

  • 20. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
    Jeppsson A, Wikkelsö C, Blennow K, Zetterberg H, Constantinescu R, Remes AM, Herukka SK, Rauramaa T, Nagga K, Leinonen V, Tullberg M.
    J Neurol Neurosurg Psychiatry; 2019 Oct 07; 90(10):1117-1123. PubMed ID: 31167811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.